ask="2.400"
ask_size="100"
average_daily_volume="345081"
bid="2.250"
bid_size="3300"
book_value="4.005"
change="-0.035"
change_from_200_day_moving_average="-3.250"
change_from_50_day_moving_average="-1.115"
change_from_52_week_high="-7.145"
change_From_52_week_low="0.205"
change_in_percent="-1.563%"
close="2.205"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.957"
ebitda="-30.59M"
eps_estimate_current_year="-2.080"
eps_estimate_next_quarter="-0.530"
eps_estimate_next_year="-1.690"
ex_dividend_date="N/A"
float_shares="8427000"
high="2.399"
high_52_weeks="9.350"
last_trade_date="1/3/2017"
last_trade_price="2.205"
last_trade_size="200"
last_trade_time="3:59pm"
low="2.150"
low_52_weeks="2.000"
market_capitalization="34.27M"
moving_average_200_day="5.455"
moving_average_50_day="3.320"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.080"
open="2.260"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-59.576%"
percent_change_from_50_day_moving_average="-33.594%"
percent_change_from_52_week_high="-76.417%"
percent_change_from_52_week_low="+10.250%"
previous_close="2.240"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.559"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.400"
stock_exchange="NGM"
symbol="NVLS"
volume="946416"
weeks_range_52="2.000 - 9.350"
